--- title: "12 Health Care Stocks Moving In Wednesday's Intraday Session" type: "News" locale: "en" url: "https://longbridge.com/en/news/281405374.md" description: "In Wednesday's trading session, Cyclerion Therapeutics (CYCN) saw a significant gain of 307.1%, reaching $6.31, while Axe Compute (AGPU) rose by 94.44% to $3.15. Other notable gainers included Regencell Bioscience (RGC) up 39.99% and Cognition Therapeutics (CGTX) up 26.26%. Conversely, ORIC Pharmaceuticals (ORIC) fell 27.3% to $9.21, and Bristol-Myers Squibb's CELGR dropped 26.39%. IO Biotech (IOBT) and BioAtla (BCAB) also experienced declines of 25.9% and 22.24%, respectively. Q4 earnings reports influenced several stock movements." datetime: "2026-04-01T17:06:03.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/281405374.md) - [en](https://longbridge.com/en/news/281405374.md) - [zh-HK](https://longbridge.com/zh-HK/news/281405374.md) --- # 12 Health Care Stocks Moving In Wednesday's Intraday Session ### Gainers - **Cyclerion Therapeutics** (NASDAQ:CYCN) shares rose 307.1% to $6.31 during Wednesday's regular session. The market value of their outstanding shares is at $5.8 million. - **Axe Compute** (NASDAQ:AGPU) shares increased by 94.44% to $3.15. The market value of their outstanding shares is at $5.4 million. As per the press release, Q4 earnings came out yesterday. - **Regencell Bioscience** (NASDAQ:RGC) stock increased by 39.99% to $35.6. The market value of their outstanding shares is at $12.5 billion. - **Cognition Therapeutics** (NASDAQ:CGTX) stock rose 26.26% to $0.96. The company's market cap stands at $67.8 million. As per the press release, Q4 earnings came out 4 days ago. - **Jaguar Health** (NASDAQ:JAGX) shares rose 22.67% to $0.45. The company's market cap stands at $4.6 million. - **Alector** (NASDAQ:ALEC) shares moved upwards by 20.0% to $2.58. The company's market cap stands at $234.6 million. ### Losers - **ORIC Pharmaceuticals** (NASDAQ:ORIC) stock fell 27.3% to $9.21 during Wednesday's regular session. The market value of their outstanding shares is at $1.4 billion. - **Bristol-Myers Squibb Company Celegne Contingent Value Rights** (NYSE:CELGR) stock fell 26.39% to $0.09. - **IO Biotech** (NASDAQ:IOBT) shares fell 25.9% to $0.04. The company's market cap stands at $4.2 million. - **BioAtla** (NASDAQ:BCAB) shares fell 22.24% to $0.13. The market value of their outstanding shares is at $13.3 million. As per the news, the Q4 earnings report came out yesterday. - **HCW Biologics** (NASDAQ:HCWB) shares declined by 17.87% to $0.3. The market value of their outstanding shares is at $1.2 million. As per the news, the Q4 earnings report came out yesterday. - **ENvue Medical** (NASDAQ:FEED) shares decreased by 16.39% to $1.99. The market value of their outstanding shares is at $2.5 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/ This article was generated by Benzinga's automated content engine and reviewed by an editor. ### Related Stocks - [PBE.US](https://longbridge.com/en/quote/PBE.US.md) - [RGC.US](https://longbridge.com/en/quote/RGC.US.md) - [XLV.US](https://longbridge.com/en/quote/XLV.US.md) - [IOBT.US](https://longbridge.com/en/quote/IOBT.US.md) - [CYCN.US](https://longbridge.com/en/quote/CYCN.US.md) - [ORIC.US](https://longbridge.com/en/quote/ORIC.US.md) - [BMY.US](https://longbridge.com/en/quote/BMY.US.md) - [IBB.US](https://longbridge.com/en/quote/IBB.US.md) - [FBT.US](https://longbridge.com/en/quote/FBT.US.md) - [LABU.US](https://longbridge.com/en/quote/LABU.US.md) - [VHT.US](https://longbridge.com/en/quote/VHT.US.md) - [IHE.US](https://longbridge.com/en/quote/IHE.US.md) - [BIB.US](https://longbridge.com/en/quote/BIB.US.md) - [CELG.RT.US](https://longbridge.com/en/quote/CELG.RT.US.md) - [BCAB.US](https://longbridge.com/en/quote/BCAB.US.md) - [AGPU.US](https://longbridge.com/en/quote/AGPU.US.md) - [XBI.US](https://longbridge.com/en/quote/XBI.US.md) - [BBH.US](https://longbridge.com/en/quote/BBH.US.md) - [CGTX.US](https://longbridge.com/en/quote/CGTX.US.md) - [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md) - [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md) - [IOBTQ.US](https://longbridge.com/en/quote/IOBTQ.US.md) ## Related News & Research - [Cognition Therapeutics Targets Faster DLB Psychosis Path as Zervimesine Nears Late-Stage Plans](https://longbridge.com/en/news/282587410.md) - [BUZZ-Needham initiates coverage of MapLight on schizophrenia drug potential](https://longbridge.com/en/news/282027609.md) - [FDA Again Rejects Replimune Skin Cancer Therapy, Says Evidence Falls Short](https://longbridge.com/en/news/282376421.md) - [Should Positive Elsunersen Data And Relutrigine Priority Review Shift the Narrative for Praxis (PRAX) Investors?](https://longbridge.com/en/news/282419526.md) - [FDA issues complete response letter to Replimune’s RP1 for melanoma](https://longbridge.com/en/news/282511585.md)